Stocks Technology DH
NASDAQ · TechnologyDefinitive Healthcare Corp. (DH)
Definitive Healthcare Corp. brought in $232.7M of revenue over the twelve months to June 30, 2026, down 5.0% from a year earlier. It posted a net loss of $168.2M. Operating cash flow minus capital spending left $37.1M of free cash flow in fiscal 2025. At June 30, 2026 it held $170.9M in cash against $160.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
Key facts about Definitive Healthcare Corp.
- Net worth
- Definitive Healthcare Corp. has a market value (market cap) of $162.4M at the latest share price, and shareholders' equity of $187.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $241.5M (-4.2% year on year), with a net loss of $138.9M. Over the 12 months to June 30, 2026: revenue $232.7M, net loss $168.2M.
- Cash flow
- In fiscal 2025 operations brought in $53.8M of cash; after $16.7M of capital spending, free cash flow was $37.1M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 10, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Definitive Healthcare Corp.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.
What Definitive Healthcare Corp. does
Definitive Healthcare Corp. is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NASDAQ under the ticker DH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $241.5M | -$138.9M | -$1.30 | $37.1M |
| 2024 | $252.2M | -$413.1M | -$3.54 | $45.9M |
| 2023 | $251.4M | -$202.4M | -$1.79 | $38.2M |
| 2022 | $222.7M | -$7.2M | -$0.07 | $27.3M |
| 2021 | $166.2M | -$17.8M | -$0.19 | $18.5M |
| 2021 | $118.3M | $0 | n/a | $21.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where DH ranks in Technology
Latest SEC filings
What Definitive Healthcare Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 1, 2026Activist stake changed SCHEDULE 13D/A
- September 9, 2026
- September 2, 2026Other event 8-K
- September 2, 2026Activist stake (5% or more) SCHEDULE 13D
- September 2, 2026
- September 2, 2026Activist stake (5% or more) SCHEDULE 13D
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 9.1% to $55.2M versus the same quarter last year; diluted EPS -$0.05 versus -$0.07.
- August 10, 2026
- June 24, 2026
- June 5, 2026
What is DH worth? A DCF from its reported cash flow
Insider trades
What the people running Definitive Healthcare Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Paris JonathanChief Legal Officer | Shares withheld for tax | 7,729 | $7.2K |
| October 1, 2026 | Heller CaseyChief Financial Officer | Shares withheld for tax | 12,542 | $11.7K |
| September 1, 2026 | Heller CaseyChief Financial Officer | Shares withheld for tax | 41,093 | $37.1K |
| August 1, 2026 | Heller CaseyChief Financial Officer | Shares withheld for tax | 1,881 | $1.3K |
| August 1, 2026 | Krantz Jason RonaldDirector, 10% owner | Shares withheld for tax | 12,166 | $8.3K |
| July 1, 2026 | Paris JonathanChief Legal Officer | Shares withheld for tax | 30,591 | $24.5K |
| July 1, 2026 | Coop KevinChief Executive Officer, Director | Shares withheld for tax | 37,593 | $30.1K |
| June 4, 2026 | Hamood Samuel ADirector | Received as pay | 189,190 | - |
Who owns DH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Advent International, L.P.13D, may seek influence with 3 related filers | 58.54% | October 1, 2026 |
| Jason Ronald Krantz13D, may seek influence | 17.6% | September 2, 2026 |
| Massachusetts Financial Services Company ("MFS")13G, passive | 5.2% | November 12, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 100 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Advent International, L.P. | 62,493,676 | 0 |
| Goldman Sachs Group Inc | 5,959,143 | -84,757 |
| D. E. Shaw & Co., Inc. | 1,973,193 | -126,358 |
| Vanguard Capital Management LLC | 1,829,463 | -36,866 |
| Kennedy Capital Management LLC | 1,737,044 | new |
| Dimensional Fund Advisors LP | 1,453,209 | -213,160 |
| BlackRock, Inc. | 1,408,621 | -1,576,946 |
| Aqr Capital Management LLC | 899,132 | +197,109 |
| Geode Capital Management, LLC | 550,753 | -628,941 |
| Renaissance Technologies LLC | 525,040 | +13,900 |
| Two Sigma Investments, LP | 509,328 | +275,747 |
| Jacobs Levy Equity Management, Inc | 472,710 | +173,237 |
| Corient Private Wealth LP | 454,486 | new |
| Arrowstreet Capital, Limited Partnership | 404,124 | -24,818 |
| Squarepoint Ops LLC | 351,575 | +111,634 |
| Barclays PLC | 323,670 | -2,810 |
| Millennium Management LLC | 275,896 | -314,486 |
| Pinnacle Associates Ltd | 260,037 | +37 |
| Pinnacle Wealth Management Advisory Group, LLC | 260,037 | +37 |
| Morgan Stanley | 254,149 | -170,152 |
Insiders
9 insiders reported holding 11,354,698 shares in total, about $12.7M at the last price.
| Holder | Shares |
|---|---|
| Coop KevinChief Executive Officer, Director | 4,975,229 |
| Heller CaseyChief Financial Officer | 1,785,960 |
| Graboske BenjaminEVP, Chief Data Officer | 1,312,027 |
| Krantz Jason RonaldDirector, 10% owner | 1,189,272 |
| Paris JonathanChief Legal Officer | 864,534 |
| Chilukuri SastryDirector | 315,984 |
| Stephenson Scott GDirector | 313,314 |
| Winters Kathleen ADirector | 308,982 |
| Hamood Samuel ADirector | 289,396 |
Questions about DH
What does Definitive Healthcare Corp. do?
Definitive Healthcare Corp. is a company in the Technology sector, listed on NASDAQ as DH. Its shares trade on NASDAQ under the ticker DH.
What is Definitive Healthcare Corp.'s net worth?
Definitive Healthcare Corp. has a market value (market cap) of $162.4M at the latest share price, and shareholders' equity of $187.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Definitive Healthcare Corp. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $168.2M on revenue of $232.7M.
How much revenue does Definitive Healthcare Corp. make?
Over the twelve months to June 30, 2026 Definitive Healthcare Corp. reported revenue of $232.7M. That is 5.0% less than a year earlier.
When did Definitive Healthcare Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 5, 2026.
When is Definitive Healthcare Corp.'s next earnings report?
Definitive Healthcare Corp.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.
Similar companies
Compare DH with
Follow DH
Get an email when Definitive Healthcare Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Definitive Healthcare Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.